Month: January 2019

A shareholder lawsuit filed Thursday claims that Alphabet’s board of directors, including Larry Page, Sergey Brin, and Eric Schmidt, covered up sexual harassment by numerous Google executives, including Andy Rubin, whose $90 million exit package was approved by the board after an internal investigation found sexual harassment claims against Rubin credible. At a press conference
0 Comments
China’s inflation rose less than expected for the month of December, official data showed on Thursday. The country’s December producer inflation rose 0.9 percent on-year, lower than the 1.6 percent economists were expecting in a Reuters poll. China’s December consumer inflation (CPI) — a gauge of prices for goods and services — rose 1.9 percent
0 Comments
About 15 percent of their members also joined their flex program, a loyalty scheme that helps participants get priority bookings and better prices. A Roam spokesperson told CNBC they are not concerned about targeting demographics or the “proverbial late-twenties marketing freelancer.” “We don’t have any age limit or preference as it goes against what we
0 Comments
Patient investors might want to consider buying shares of Micron Technology as things slowly turn positive for the chipmaker, CNBC’s Jim Cramer said Monday as Micron’s stock pulled the semicondcutor cohort higher. Shares of Micron mounted a long-awaited recovery in Monday’s turbulent trading session after BMO Capital Markets analysts upgraded the stock to “buy” from
0 Comments
On the latest episode of Recode Media with Peter Kafka, Dotdash CEO Neil Vogel joined Peter in our studio to talk about a media turnaround story: His team took an aging internet property, the once-mighty About.com, and rebuilt it into a modern network of sites answering people’s questions about topics like health, food, and personal
0 Comments
Bristol-Myers Squibb agreed to acquire Celgene in a record-sized $74 billion deal that will unite two drug makers battling for advantage in a crowded market for innovative cancer treatments. The cash-and-stock deal will be the largest pharma acquisition of all time; analysts say it could trigger a flood of biotech deals. In purchasing Celgene, Bristol
0 Comments
As the government shutdown stretches into its second week with no end in sight, about 380,000 federal employees are bracing for the worst — deferring payments, filing unemployment claims and notifying landlords that they might not make rent. An additional 420,000 employees deemed essential are working without pay. On Monday, the American Federation of Government
0 Comments
Results of a private survey on China’s manufacturing activity for the month of December will be released at 9:45 a.m. SIN/HK on Wednesday, shedding more light on the state of the world’s second-largest economy amid a trade dispute with the U.S. The Caixin/Markit Manufacturing Purchasing Managers’ index (PMI), a private survey, is expected to show
0 Comments